Delivery Order SPE2DB22D3501-SPE2DB25FWX37
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,103.51 to AmerisourceBergen Drug Corp for Infuvite Pediatric Vial 5ML, a pediatric nutritional supplement product. The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and was competitively awarded without set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Infuvite Pediatric Bulk Vial 50ML, a pediatric parenteral nutrition product. The delivery order, valued at $3,244.45, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $25.8K delivery order to AmerisourceBergen Drug Corp for INFUVITE PEDIATRIC VIAL 5ML, a pediatric intravenous nutritional product. Issued on June 11, 2025, with an ultimate completion date of June 12, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,014.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,031.97 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,460.20 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a pharmaceutical product. The award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract falling under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,300.14 to AmerisourceBergen Drug Corp for INFUVITE Adult Vial 10ML, a parenteral nutrition product used in clinical settings. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and operates under firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,620.21 to AmerisourceBergen Drug Corp for the supply of Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitively awarded, firm fixed price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $11,265.34 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product used in clinical settings. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWX37Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,435.68 to AmerisourceBergen Drug Corp for Infuvite Pediatric Bulk Vial 50ML, a pharmaceutical product for pediatric intravenous nutrition support. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medical products including specialty medications, generic and brand-name drugs, vaccines, and medical supplies to support military healthcare systems globally. The contract serves critical federal healthcare customers including the Defense Health Agency and the U.S. Coast Guard, with the DLA planning future expansion through its Pharmaceutical Prime Vendor Global Program Generation V initiative involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/18/25 |